» Authors » Terrence T Fitzgerald

Terrence T Fitzgerald

Explore the profile of Terrence T Fitzgerald including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 353
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Blue T, Gordon M, Schwartz R, Couvillion K, Vocci F, Fitzgerald T, et al.
Addict Sci Clin Pract . 2019 Dec; 14(1):45. PMID: 31787108
Background: It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison...
2.
Gordon M, Blue T, Couvillion K, Schwartz R, OGrady K, Fitzgerald T, et al.
Drug Alcohol Depend . 2018 May; 188:232-238. PMID: 29783095
Background: This secondary analysis of a randomized trial examines the association between initiation of buprenorphine treatment prior to, versus post-release, and rearrests during the 12-months following release. Methods: Official rearrest...
3.
Gordon M, Kinlock T, Schwartz R, OGrady K, Fitzgerald T, Vocci F
Drug Alcohol Depend . 2017 Jan; 172:34-42. PMID: 28107680
Background: This study examined whether starting buprenorphine treatment prior to prison and after release from prison would be associated with better drug treatment outcomes and whether males and females responded...
4.
Gordon M, Vocci F, Fitzgerald T, OGrady K, OBrien C
Contemp Clin Trials . 2016 Dec; 53:130-136. PMID: 28011389
Background: Extended-release naltrexone (XR-NTX), is an effective treatment for opioid use disorder but is rarely initiated in US prisons or with criminal justice populations. Mobile treatment for chronic diseases has...
5.
Vocci F, Schwartz R, Wilson M, Gordon M, Kinlock T, Fitzgerald T, et al.
Drug Alcohol Depend . 2015 Sep; 156:133-138. PMID: 26409751
Background: In a previously reported randomized controlled trial, formerly opioid-dependent prisoners were more likely to enter community drug abuse treatment when they were inducted in prison onto buprenorphine/naloxone (hereafter called...
6.
Gordon M, Kinlock T, Vocci F, Fitzgerald T, Memisoglu A, Silverman B
J Subst Abuse Treat . 2015 Aug; 59:52-8. PMID: 26299956
This was a Phase 4, pilot, open-label feasibility study of extended-release injectable naltrexone (XR-NTX) administered to pre-release prisoners having a history of pre-incarceration opioid disorder. We evaluated the relationship between...
7.
Gordon M, Kinlock T, Schwartz R, Fitzgerald T, OGrady K, Vocci F
Drug Alcohol Depend . 2014 Jun; 142:33-40. PMID: 24962326
Background: Buprenorphine is a promising treatment for heroin addiction. However, little is known regarding its provision to pre-release prisoners with heroin dependence histories who were not opioid-tolerant, the relative effectiveness...
8.
Kinlock T, Gordon M, Schwartz R, Fitzgerald T
J Offender Rehabil . 2010 May; 49(2):91-109. PMID: 20473351
Research suggests that buprenorphine treatment may be a promising intervention for incarcerated individuals with heroin addiction histories. However, its implementation varies from corrections-based methadone because of unique challenges regarding dosing,...
9.
Kinlock T, Gordon M, Schwartz R, Fitzgerald T, OGrady K
J Subst Abuse Treat . 2009 Apr; 37(3):277-85. PMID: 19339140
This study examined the impact of prison-initiated methadone maintenance at 12 months postrelease. Males with pre-incarceration heroin dependence (N = 204) were randomly assigned to (a) Counseling Only: counseling in...
10.
Kinlock T, Gordon M, Schwartz R, OGrady K, Fitzgerald T, Wilson M
Drug Alcohol Depend . 2007 Jul; 91(2-3):220-7. PMID: 17628351
Background: Despite its effectiveness, methadone maintenance is rarely provided in American correctional facilities. This study is the first randomized clinical trial in the US to examine the effectiveness of methadone...